Related references
Note: Only part of the references are listed.Expression of Functional Molecule on Plasmacytoid Dendritic Cells Is Associated With HBsAg Loss in HBeAg-Positive Patients During PEG-IFN α-2a Treatment
Weihua Cao et al.
FRONTIERS IN IMMUNOLOGY (2022)
IFNAR1 and IFNAR2 play distinct roles in initiating type I interferon-induced JAK-STAT signaling and activating STATs
Maya Shemesh et al.
SCIENCE SIGNALING (2021)
The Characteristics of Natural Killer Cells in Chronic Hepatitis B Patients Who Received PEGylated-Interferon versus Entecavir Therapy
Weihua Cao et al.
BIOMED RESEARCH INTERNATIONAL (2021)
Pegylated Interferon-α (IFN-α) Enhances the Inhibitory Effect of Natural Killer Cells on Regulatory T Cells via IFN-γ in Chronic Hepatitis B
Wei Yuan et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
The impact of hepatitis B surface antigen on natural killer cells in patients with chronic hepatitis B virus infection
Yanqin Du et al.
LIVER INTERNATIONAL (2021)
HBsAg Dampened STING Associated Activation of NK Cells in HBeAg-Negative CHB Patients
Bingqing Zheng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Durability of Spontaneous and Treatment-Related Loss of Hepatitis B s Antigen
Ahmad Samer Alawad et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Have the Starting Lineup of Five for Hepatitis B Virus Covalently Closed Circular DNA Synthesis Been Identified?
Qiong Zhao et al.
HEPATOLOGY (2020)
Contribution of NK cells to HBsAg seroconversion in inactive HBsAg carriers following pegylated IFN therapy
Zhenhuan Cao et al.
INNATE IMMUNITY (2020)
IFNAR2Deficiency Causing Dysregulation of NK Cell Functions and Presenting With Hemophagocytic Lymphohistiocytosis
Chiara Passarelli et al.
FRONTIERS IN GENETICS (2020)
Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B
Anna S. Lok et al.
HEPATOLOGY COMMUNICATIONS (2020)
Human NK cells: surface receptors, inhibitory checkpoints, and translational applications
Simona Sivori et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Drugs in the Pipeline for HBV
Uri Lopatin
CLINICS IN LIVER DISEASE (2019)
A global scientific strategy to cure hepatitis B
Peter A. Revill et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
Systematic review with meta-analysis: combination treatment of regimens based on pegylated interferon for chronic hepatitis B focusing on hepatitis B surface antigen clearance
K. Qiu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Increased NK Cell Function After Cessation of Long-Term Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Is Associated With Liver Damage and HBsAg Loss
Christine L. Zimmer et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
CD56bright natural killer cells induce HBsAg reduction via cytolysis and cccDNA decay in long-term entecavir-treated patients switching to peginterferon alfa-2a
A. Shi et al.
JOURNAL OF VIRAL HEPATITIS (2018)
Hepatitis B cure: From discovery to regulatory approval
Anna S. Lok et al.
JOURNAL OF HEPATOLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Veritable antiviral capacity of natural killer cells in chronic HBV infection: an argument for an earlier anti-virus treatment
Xiaoyan Li et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
Markers and Function of Human NK Cells in Normal and Pathological Conditions
Genny Del Zotto et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2017)
Serum hepatitis B surface antigen correlates with tissue covalently closed circular DNA in patients with hepatitis B-associated hepatocellular carcinoma
Qin Wang et al.
JOURNAL OF MEDICAL VIROLOGY (2016)
Combination of Tenofovir Disoproxil Fumarate and Peginterferon alpha-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B
Patrick Marcellin et al.
GASTROENTEROLOGY (2016)
Hepatitis B virus antigens impair NK cell function
Yinli Yang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Interferon Alpha Induces Sustained Changes in NK Cell Responsiveness to Hepatitis B Viral Load Suppression In Vivo
Upkar S. Gill et al.
PLOS PATHOGENS (2016)
Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion
Juliana Bruder Costa et al.
PLOS ONE (2016)
Natural killer cells in hepatitis B virus infection
Shao-fei Wu et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2015)
Activated natural killer cells accelerate liver damage in patients with chronic hepatitis B virus infection
Q. Zheng et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Natural Killer p46 Controls Hepatitis B Virus Replication and Modulates Liver Inflammation
Wanyu Li et al.
PLOS ONE (2015)
Natural Killer Cells in Viral Hepatitis
Barbara Rehermann
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2015)
Interferon Therapy of Chronic Hepatitis B
Maurizia Rossana Brunetto et al.
INTERVIROLOGY (2014)
Compromised Function of Natural Killer Cells in Acute and Chronic Viral Hepatitis
Sebastian Lunemann et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Natural Killer Cells Are Characterized by the Concomitantly Increased Interferon-γ and Cytotoxicity in Acute Resolved Hepatitis B Patients
Juanjuan Zhao et al.
PLOS ONE (2012)
Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B
Eric T. T. L. Tjwa et al.
JOURNAL OF HEPATOLOGY (2011)
Natural killer cells in viral hepatitis: facts and controversies
Mario U. Mondelli et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
Clearance of Hepatitis B Surface Antigen and Risk of Hepatocellular Carcinoma in a Cohort Chronically Infected with Hepatitis B Virus
Josephine Simonetti et al.
HEPATOLOGY (2010)
Incubation phase of acute hepatitis B in man: Dynamic of cellular immune mechanisms
GJM Webster et al.
HEPATOLOGY (2000)
Share Paper
